These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3071278)

  • 1. [Vaccination against cholera: what prospects?].
    Pierre P; Lucas G; Vaerman JP
    Ann Soc Belg Med Trop; 1988 Jun; 68(2):83-93. PubMed ID: 3071278
    [No Abstract]   [Full Text] [Related]  

  • 2. [The prospects for improving chemical cholera vaccines].
    Markov EIu; Maramovich AS; Golubinskiĭ EP; Urbanovich LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):91-6. PubMed ID: 9783412
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.
    Viret JF; Dietrich G; Favre D
    Vaccine; 2004 Jun; 22(19):2457-69. PubMed ID: 15193410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 5. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of Vibrio antibody titers during anti-cholera vaccination].
    Dirimci OT; Cinar V
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
    [No Abstract]   [Full Text] [Related]  

  • 10. Attenuated recombinant strains of Vibrio cholerae for oral immunization.
    Srivastava BS; Sinha VB; Srivastava R
    Bull World Health Organ; 1979; 57(4):649-54. PubMed ID: 316742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design of cholera vaccines.
    Manning PA
    Vaccine; 1992; 10(14):1015-21. PubMed ID: 1361701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains.
    García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G
    Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073
    [No Abstract]   [Full Text] [Related]  

  • 13. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera vaccines.
    Kabir S
    Lancet Infect Dis; 2007 Mar; 7(3):176-8; author reply 178. PubMed ID: 17317594
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of vaccination against cholera and typhoid fever.
    Germanier R
    Monogr Allergy; 1975; 9():217-30. PubMed ID: 1090807
    [No Abstract]   [Full Text] [Related]  

  • 16. [Developmental aspects of organism immunoreactivity in vaccination against cholera (author's transl)].
    Gorkova AV; Kuznĕcov OR; Naumsina MS; Adamov AK
    Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):136-42. PubMed ID: 126811
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of a live oral cholera vaccine in human volunteers.
    Woodward WE; Gilman RH; Hornick RB; Libonati JP; Cash RA
    Dev Biol Stand; 1976; 33():108-12. PubMed ID: 782960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New attenuated derivatives of Vibrio cholerae.
    Pearson GD; DiRita VJ; Goldberg MB; Boyko SA; Calderwood SB; Mekalanos JJ
    Res Microbiol; 1990; 141(7-8):893-9. PubMed ID: 2101479
    [No Abstract]   [Full Text] [Related]  

  • 19. Simultaneous vaccination against cholera and yellow fever.
    Felsenfeld O; Wolf RH; Gyr K; Grant LS; Dutta NK
    Lancet; 1973 Mar; 1(7801):457-8. PubMed ID: 4120368
    [No Abstract]   [Full Text] [Related]  

  • 20. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
    Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.